|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
Sources: |
Abbott Laboratories, “Cylert,” American Journal of Diseases of Children, www.bonkersinstitute.org, 1976 Adforum.com, “Zelnorm – ‘N/A’ – Deutsch NY,” www.adforum.com (accessed Feb. 7, 2014) AP, “Drug Maker Pleads Guilty over Lethal Side Effects,” www.nytimes.com, Dec. 14, 1984 AstraZeneca, “AstraZeneca Decides to Withdraw Exanta TM,” www.astrazeneca.com, Feb. 14, 2006 Michelle R. Carter and Sorour Amirhaeri, “p-ANCA-Associated Vasculitis Caused by Levamisole-Adulterated Cocaine: A Case Report,” Case Reports in Emergency Medicine, www.hindawi.com, 2013 Marlene Cimons, “Seldane Pulled for a Safer Allergy Drug,” www.latimes.com, Dec. 30, 1997 Dan Collins, “Insider: FDA Won’t Protect Public,” www.cbsnews.com, Dec. 7, 2004 Richard DeGrandpre, The Cult of Pharmacology: How America Became the World’s Most Troubled Drug Culture, 2006 “Drugs: The Dangers of Analgesics,” www.time.com, Feb. 24, 1967 Drugwatch, “What Is Accutane? It’s Uses and Interactions,” www.drugwatch.com/accutane, Dec. 10, 2013 Fairfield State Hospital, “Metrazol Therapy,” www.fairfieldstatehospital.com, Jan. 15, 2013 FDA, “FDA Alerts Consumers of Undeclared Drug Ingredients in Over-the-Counter Diabetes Product,” www.fda.gov, July 23, 2013 FDA, “FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-Phen),” www.fda.gov, Sep. 15, 1997 FDA, “FDA Announces Voluntary Withdrawal of Pergolide Products: Agency Working with Product Manufacturers,” www.fda.gov, Mar. 29, 2007 FDA, “FDA Approves First Treatment for Women with Constipation-Predominant Irritable Bowel Syndrome,” www.web.archive.org, July 24, 2002 FDA, “FDA Drug Safety Communication: Voluntary Market Withdrawal of Xigris [drotrecogin alfa (activated)] Due to Failure to Show a Survival Benefit,” www.fda.gov, Oct. 25, 2011 FDA, “FDA Issues Public Health Advisory for Trasylol,” www.fda.gov, Feb. 8, 2006 FDA, “FDA: Pfizer Voluntarily Withdraws Cancer Treatment Mylotarg from U.S. Market,” www.fda.gov, June 21, 2010 FDA, “FDA Requests Marketing Suspension of Trasylol,” www.fda.gov, Nov. 5, 2007 FDA, “How Does FDA Decide When a Drug Is not Safe enough to Stay on the Market,” www.fda.gov, Jan. 7, 2010 FDA, “Information for Healthcare Professionals: Pemoline Tablets and Chewable Tablets (marketed as Cylert),” www.fda.gov, Oct. 2005 FDA, “Information for Healthcare Professionals: Valdecoxib (marketed as Bextra),” www.fda.gov, Apr. 7, 2005 FDA, “Propulsid (cisapride) Dear Healthcare Professional Letter Jan 2000,” www.fda.gov, Jan 24, 2000 FDA, “Propoxyphene: Withdrawal – Risk of Cardiac Toxicity,” www.fda.gov, Nov. 19, 2010 FDA, “Public Health Advisory: Suspended Marketing of Palladone (hydromophone hydrocloride, extended-release capsules),” www.fda.gov, July 13, 2005 FDA, “Questions and Answers about Withdrawal of Duract,” www.fda.gov, Aug. 23, 2013 FDA, “Questions and Answers about Withdrawal of Fenfluramine (Pondimine) and Dexfenfluramine (Redux),” www.fda.gov, July, 7, 2005 FDA, “Raplon (Rapacuronium Bromide),” www.fda.gov, Mar. 29, 2001 FDA, “Recalling the Omniflox (Temafloxacin) Tablets,” June 5, 1992 FDA, “FDA Statement on the Voluntary Withdrawal of Raptiva from the U.S. Market,” www.fda.gov, Apr. 8, 2009 FDA, “Withdrawal of Product: RAXAR (grepafloxin HCL) 600 mg Tablets, 400 mg Tablets, and 200 mg Tablets,” www.fda.gov, Nov. 1, 1999 FDA, “Zelnorm (tegaserod maleate) Information,” www.fda.gov, May 11, 2012 Jef Feeley, “Pfizer Ends Rezulin Cases with $205 Million to Spare (Update1),” www.bloomberg.com, Mar. 31, 2009 Barbara Forney, “Pergolide for Veterinary Use,” www.wedgewoodpetrx.com (accessed Jan. 6, 2014) Curt D. Furgerg and Bertram Pitt, “Withdrawal of Cerivastatin from the World Market,” www.ncbi.nlm.nih.gov, Sep. 26, 2001 Raymond Goldberg, Drugs across the Spectrum, 6th edition, 2010 Barbara Hammes and Cynthia Laitman, “Pharmaceutical Company Advertisement for DES by the Grant Chemical Company, Brooklyn, NY, Printed in the American Journal of Obstetrics & Gynecology in 1957,” Journal of Midwifery and Women’s Health, www.medscape.com, 2003 David Healy, Let Them Eat Prozac: The Unhealthy Relationship between the Pharmaceutical Industry and Depression, 2004 Charles D. Helper and Richard Segal, Preventing Medication Errors and Improving Drug Therapy Outcomes: A Management Systems Approach, 2003 Irritable Bowel Syndrome Self Help and Support Group, “Lotronex,” www.ibsgroups.org (accessed Jan. 6, 2014) Harvey Kirk, “Darvon and Darvocet Deaths Lead FDA Panel to Recommend Recall,” www.youhavealawyer.com, Feb. 2, 2009 Lilly, “Lilly Announces Withdrawal of Xigris R Following Recent Clinical Trial Results,” www.fda.gov, Oct. 25, 2011 National Cancer Institute, “Diethylstilbestrol (DES) and Cancer,” www.cancer.gov, Oct. 5, 2011 Steven Morris, “Abbott Gets FDA Approval for Omniflox Antibiotic,” www.chicagotribune.com, Feb. 1, 1992 MSNBC Staff, “Report: Vioxx Linked to Thousands of Deaths,” www.nbcnews.com, Oct. 6, 2004 Pink Sheet, “FDA Clears Treatment IND for Colon Cancer Drug Levamisole,” www.elsevierbi.com, May 15, 1989 Res Obscura, “From Quacks to Quaaludes: Three Centuries of Drug Advertising,” www.resobscura.blogspot.nl, June 11, 2012 Renato M.E. Sabbatini, “The History of Shock Therapy in Psychiatry,” www.crerbromente.org.br (accessed Dec. 19, 2013) Christian Sinclair, “Are You Glad Darvocet Got Pulled by the FDA? Are You Sure?,” www.pallimed.org, Nov. 30, 2010 Sheryl Gay Stolberg, “New Painkiller Is Withdrawn after 4 Deaths,” www.nytimes.com, June 23, 1998 Bernadette Tansey, “Hard Sell: How Marketing Drives the Pharmaceutical Industry/The Side Effects of Drug Promotion/Aggressive Ads for Painkillers Left More Patients Exposed to Risk,” www.sfgate.com, Feb. 27, 2005 Forest Tennant, “Hughes & Pseudoaddiction,” Practical Pain Management, www.pain-topics.org, July/Aug. 2007 Today’s Seniors Network, “This Is Patient Education?,” www.todaysseniorsnetwork.com (accessed Jan. 7, 2014) David Willman, “Diabetes Drug Rezulin Pulled Off the Market,” www.pulitzer.org, Mar. 22, 2000 David Willman, “Drug Lotronex Pulled over Safety Fears,” www.pulitzer.org, Nov. 29, 2000 Wei Zhang, Mary W. Roederer, Wang-Qing Chen, Lan Fan, and Hong-Hao Zhou, “Pharmacogenetics of Drugs Withdrawn from the Market,” Pharmacogenomics, www.medscape.com, 2012
|
People who view this page may also like: |
---|
1. 2016 Presidential Candidates' Positions: Should Genetically Modified (GMO) Foods Have Mandatory Labeling? |
2. 35 FDA-Approved Prescription Drugs Later Pulled from the Market |
3. Drug Ads Gallery, 1800s-2014 |